Rhaeos was founded by Dr. Chad Webb, John A. Rogers, Roozbeh Ghaffari, Anna Lisa Somera in 2018.

Who are Rhaeos's investors?

Rhaeos's investors include Creative Ventures, Portal Innovations, Lateral Capital.

How much funding has Rhaeos raised?

Rhaeos has disclosed $6.2M raised across 1 of its 2 known rounds.

Where is Rhaeos headquartered?

Rhaeos is headquartered in Evanston, US.

Rhaeos

Evanston, US · Founded 2018 · Delaware corporation · 16 employees on LinkedIn · 3 known investors

Find your way into Rhaeos

298 people in our graph share verified history with the Rhaeos team — schools, employers, funds. One of them is your warm intro.

Chaya Patelunlockedknows Anna Lisa Somera · together at Women In Bio (overlapped)

knows the team · via Women In Bio

×4knows the team · via University of Illinois Chicago

knows the team · via Rush University

×2knows the team · via University of Illinois Office of Technology Mgmt

×3knows the team · via Loyola University Chicago

Rhaeos develops FlowSense, a noninvasive wireless wearable skin patch that monitors fluid flow in the body, initially targeting hydrocephalus patients who depend on implantable shunts for cerebrospinal fluid management.

Hardware Healthtech Medical Devices

Founders & leadership

Rhaeos was founded in 2018 by Dr. Chad Webb, John A. Rogers, Roozbeh Ghaffari, and Anna Lisa Somera.

Dr. Chad Webb

John A. RogersCo-founder

Roozbeh GhaffariinCo-founder · Member Board Of DirectorsExecutive Officer, Director at Epicore Biosystems

Anna Lisa Somera inCo-founder · Chief Strategy OfficerAnna Lisa Somera holds graduate degrees in cell biology, business, and public health, and has spent over two decades in early-stage biomedical ventures, medical device operations, and regulatory affairs; she founded Rhaeos, where she serves as Chief Strategy Officer and has led the company through multiple funding rounds and regulatory milestones including FDA breakthrough designation.

Chad SeaverNamed on SEC filing

R. Chad WebbNamed on SEC filing

Adam ZyskNamed on SEC filing

Investors · 3

Creative VenturesSan Francisco Bay Area · $1M

Portal InnovationsChicago

Lateral CapitalreportedNairobi · $100K – $1M

Funding

SEC filings, press & company announcements

$6.2M disclosed across 1 of 2 rounds · 2021–2023

Undisclosed amountSeed RoundDec 2021
Source ↗

▶$6.2MraisedMar 2023 · 23 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Chad SeaverDirector
John A. RogersExecutive Officer, Director
R. Chad WebbExecutive Officer, Director
Roozbeh GhaffariDirector
Anna Lisa SomeraExecutive Officer
Adam ZyskExecutive Officer

Offering amount: $13M
Amount sold: $6.2M
First sale: Feb 2023
Incorporated: Corporation, Delaware, 2018
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 4 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase II	2022	$3.1M
National Institutes of Health (NIH)National Institutes of Health	Phase I	2021	$1M
National Science Foundation	Phase II	2021	$978.6K
National Science Foundation	Phase I	2020	$225K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Rhaeos raises US$10.5 million in Series A funding to boost hydrocephalus productsneuronewsinternational.com · Feb 2023

Rhaeos Raises $10.5M in Series A Funding - FinSMEsfinsmes.com · Feb 2023

Rhaeos Raises $10.5M in Series A Funding to Launch Novel Hydrocephalus Shunt Monitor and Accelerate Pipeline Product Developmentprnewswire.com · Feb 2023

Rhaeos, Inc. Raises $2.2 Million in Oversubscribed Seed Roundprnewswire.com · Dec 2021

Frequently asked questions

What does Rhaeos do?: Rhaeos develops FlowSense, a noninvasive wireless wearable skin patch that monitors fluid flow in the body, initially targeting hydrocephalus patients who depend on implantable shunts for cerebrospinal fluid management.
Who founded Rhaeos?: Rhaeos was founded by Dr. Chad Webb, John A. Rogers, Roozbeh Ghaffari, Anna Lisa Somera in 2018.
Who are Rhaeos's investors?: Rhaeos's investors include Creative Ventures, Portal Innovations, Lateral Capital.
How much funding has Rhaeos raised?: Rhaeos has disclosed $6.2M raised across 1 of its 2 known rounds.
Where is Rhaeos headquartered?: Rhaeos is headquartered in Evanston, US.